Results 291 to 300 of about 11,359 (301)

Nash implementation: A full characterization

European Journal of Political Economy, 1991
Semih Koray, Murat Sertel
openaire   +1 more source

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Nature Reviews Gastroenterology and Hepatology, 2017
Zobair M Younossi, Quentin M Anstee, Frcp, Milena Marietti   +2 more
exaly  

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

Hepatology, 2013
Lixin Zhu
exaly  

NAFLD, NASH and liver cancer

Nature Reviews Gastroenterology and Hepatology, 2013
Gregory A Michelotti, Anna Mae Diehl
exaly  

Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials

Hepatology, 2018
Cyrielle Caussy, Scott B Reeder, Claude B Sirlin   +2 more
exaly  

Lipotoxicity and the gut-liver axis in NASH pathogenesis

Journal of Hepatology, 2018
Fabio Marra, Gianluca Svegliati-Baroni
exaly  

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Journal of Hepatology, 2017
Hannes Hagström, Patrik Nasr, Mattias Ekstedt   +2 more
exaly  

Current and future pharmacological therapies for NAFLD/NASH

Journal of Gastroenterology, 2017
Yoshio Sumida
exaly  

From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

Nature Reviews Gastroenterology and Hepatology, 2013
Alexander Wree, Ali Canbay, Hal M Hoffman   +2 more
exaly  

Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution

Nature Metabolism, 2019
Joel T Haas, Luisa Vonghia, Denis A Mogilenko   +2 more
exaly